Fully-integrated Biotechnology Company Consistently Developed Leading Innovative Therapies in Autoimmune and Oncology Therapeutic Areas
Company Profile
We focus on the urgent unmet clinical needs and are committed to providing high-quality, affordable, innovative therapies for patients in China and overseas. Our core leadership team is composed of top-notch experts in the biopharmaceutical industry, with extensive experience in the transformation of scientific and technological achievements to commercialization at home and abroad. Founded in 2016, our company is headquartered in Chengdu and expand footprints across China in Bejing, Shanghai, Wuhan, Nanjing, Guangzhou and Jinan, with over 1400 employees currently. Keymed was listed on the Main Board of Hong Kong Stock Exchange under the stock code ”2162” in 2021.
Innovation-driven through Entire Industry Chain
A fully-integrated industry chain covering end-to-end from molecules to market.
•Multiple innovative technology platforms
•Innovative antibody discovery platform
•Proprietary novel T Cell Engager (nTCE) Bispecific Antibody platform
•Antibody-Drug Conjugate (ADC) platform
•Bio-evaluation platform
•High-throughput screening platform
Diversified and World-competitive Pipeline
Consistently take on
underserved and challenging disease areas
•13 in clinical-stage development
•30+ drug development programs
International-standard Biopharmaceutical Manufacturing Facility
75,333 M2
Site area
5-15
Commercial-scale production
70,000 L
Total production capacity
Culture and Values
Vision
We are devoted to becoming a global leading biopharmaceutical company with next-generation therapeutics addressing the urgent unmet clinical needs.
Mission
With the mission of “continuous pursuit of innovation and excellence”, we are dedicated to bringing high-quality， affordable，innovative medicines to patients globally.
Values
Following patient - oriented principle, we are committed to pursuing higher standards of social value output and bringing curing hope to patients worldwide.
Management Team
Keymed was founded by medical and scientific experts who have strong experience in the transformation of scientific and technological achievements to commercialization at home and abroad.
Milestones
Keymed is steadily advancing towards becoming a comprehensive and innovative biopharmaceutical company.